The Trump administration announced a major crackdown on pharmaceutical advertising on Tuesday, targeting what officials call deceptive drug commercials that have misled Americans for decades. Health and Human Services Secretary Robert F. Kennedy Jr. and the Food and Drug Administration sent thousands of warning letters to drug companies and issued approximately 100 cease-and-desist orders to companies with what they called “deceptive” advertisements.
President Donald Trump signed a presidential memorandum directing federal agencies to ensure transparency and accuracy in direct-to-consumer prescription drug advertising. The measure goes beyond traditional TV advertising to include social media platforms and digital advertising, where officials say companies have increasingly avoided proper disclosure of side effects.
